We are delighted to announce a press release between Unilever and Neuro-Bio sharing the following : Unilever and Neuro-Bio discover a novel marker of skin aging of possible relevance to Alzheimer’s disease. In a pioneering discovery, scientists at Unilever and...
On Friday 28th of November Neuro-Bio’s CEO, Susan Greenfield, opens Aptamer Group’s new state-of-the-art laboratories and presented on the challenges in scientific discovery. To read the full article, click the link....
On Tuesday the 5th of April, Neuro-bio’s CEO, Baroness Susan Greenfield, NED, Professor Paul Herrling and Behaviourist, Stuart Williams, held a Press Conference at the Royal College of Physicians London for the publication of their latest results in Alzheimer’s...
Publishing our work in Alzheimer’s & Dementia: Translational Research & Clinical Interventions (TRCI), Neuro-Bio researchers, in collaboration with the drug discovery company Evotec SE, UCLA, and King’s College London studied the ability of their patented...
The Barclays Scale Up UK Programme addresses the core challenges businesses, founders and their senior management teams face in scaling, by providing a bespoke, hands-on approach to help you accelerate your business’ growth. Neuro-Bio has decided to participate...
ENDORSEMENT FROM THE UK REGULATORY BODY (MEDICINES & HEALTHCARE PRODUCTS REGULATORY AGENCY, MHRA) Neuro-Bio has just been awarded a ‘Passport of Innovation’ from the MHRA. The company is very much at the forefront of this new concept of ‘Innovation Licensing and...
